The role of mitochondrial-mediated apoptosis in a myelodysplastic syndrome secondary to congenital deletion of the short arm of chromosome 4

Author： Dror Y.  

Publisher： Elsevier

ISSN： 0301-472X

Source： Experimental Hematology, Vol.31, Iss.3, 2003-03, pp. : 211-217

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Secondary myelodysplastic syndrome after hydroxychloroquine therapy

By Muslimani Alaa   Spiro Timothy   Chaudhry Asif   Daw Hamed  

Annals of Hematology, Vol. 86, Iss. 7, 2007-07 ,pp. : 531-534

Springer Publishing Company

Access to resources Recommend Favorite

MHC class II-mediated apoptosis in dendritic cells: a role for membrane-associated and mitochondrial signaling pathways

By Leverkus M.  

International Immunology, Vol. 15, Iss. 8, 2003-08 ,pp. : 993-1006

Oxford University Press

Access to resources Recommend Favorite

Response to lenalidomide in patients with myelodysplastic syndrome with deletion 5q: clinical and cytogenetic analysis of a single centre series

By Coutinho Rita   Costa Dolors   Carrió Ana   Muñoz Concha   Vidal Ana   Belkaid Mohammed   Campo Elias   Nomdedeu Benet  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1069-1070

Springer Publishing Company

Access to resources Recommend Favorite

Retinol binding protein 4 plasma level in myelodysplastic syndrome subgroups

By  

International Journal Of Laboratory Hematology, Vol. 37, Iss. 5, 2015-10 ,pp. : e127-e128

John Wiley & Sons Inc

Access to resources Recommend Favorite

Caspases and apoptosis in myelodysplastic syndromes

By Mundle S.D.   Shetty V.T.   Raza A.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1310-1311

Elsevier

Access to resources Recommend Favorite